Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04928846 |
|---|---|
| Brief Title: | A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) |
| First Submitted : | June 14, 2021 |
| First Submitted that Met QC Criteria : | June 14, 2021 |
| First Posted : | June 16, 2021 |
| Last Update Submitted that Met QC Criteria : | May 13, 2024 |
| Last Update Posted : | May 14, 2024 |